
Keywords: عامل خطر; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; CK, cytokeratin; OC, oral contraceptive; HT, postmenopausal hormone therapyBreast cancer; Subtype; Risk factor; Luminal; HER2; Triple negative